NS Wind Down Co Inc (NSTGQ)

0.0781 -0.01 (-7.30%) USD  |  OTCM  |  Jun 14, 16:00
More

NS Wind Down Research and Development Expense (Quarterly): 17.12M for Sept. 30, 2023

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.
Date Value
September 30, 2023 17.12M
June 30, 2023 18.21M
March 31, 2023 16.12M
December 31, 2022 19.09M
September 30, 2022 16.99M
June 30, 2022 17.35M
March 31, 2022 17.42M
December 31, 2021 18.16M
September 30, 2021 19.12M
June 30, 2021 17.16M
March 31, 2021 15.06M
December 31, 2020 14.62M
September 30, 2020 14.99M
June 30, 2020 15.74M
March 31, 2020 17.50M
December 31, 2019 17.97M
September 30, 2019 17.01M
June 30, 2019 17.03M
March 31, 2019 16.03M
December 31, 2018 16.53M
September 30, 2018 16.65M
June 30, 2018 14.58M
March 31, 2018 13.83M
December 31, 2017 13.68M
Date Value
September 30, 2017 11.37M
June 30, 2017 11.04M
March 31, 2017 10.80M
December 31, 2016 9.996M
September 30, 2016 8.717M
June 30, 2016 8.799M
March 31, 2016 7.208M
December 31, 2015 7.071M
September 30, 2015 5.812M
June 30, 2015 5.798M
March 31, 2015 5.916M
December 31, 2014 5.437M
September 30, 2014 5.961M
June 30, 2014 5.274M
March 31, 2014 4.732M
December 31, 2013 4.51M
September 30, 2013 3.784M
June 30, 2013 3.626M
March 31, 2013 3.059M
December 31, 2012 3.382M
September 30, 2012 3.085M
June 30, 2012 2.971M
March 31, 2012 2.197M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

14.62M
Minimum
Dec 2020
19.12M
Maximum
Sep 2021
17.04M
Average
17.14M
Median

Research and Development Expense (Quarterly) Benchmarks

Bruker Corp 81.80M
Azenta Inc 8.707M
Harvard Bioscience Inc 2.885M
Bionano Genomics Inc 9.779M
Akoya Biosciences Inc 5.554M